Cyclodextrin-Based Cryogels for Controlled Drug Delivery

Cryogels are macroporous hydrogels prepared by cryo-gelation, a green technique that involves a radical polymerization using water as solvent. This method generates an interconnected pore structure that confers to material sponge-like properties. For this peculiarity, cryogels can be used as drug delivery platforms.^1,2

Due to their hydrophobic cavity, allowing non-covalent host-guest inclusion complexation with many hydrophobic molecules, cyclodextrins are well-known and FDA-approved drug delivery carriers.

In this context, we report the preparation of original super-macroporous cryogels starting from HEMA (2-hydroxyethyl methacrylate) and acrylic or styrilic functionalized a, b, or g-cyclodextrin. The macroporous structure cryogels were synthesized by free-radical polymerization in a frozen aqueous system, then purified and dried. All the materials have been extensively characterized by IR, scanning electron microscopy, and thermal gravimetry.

The carriers were successfully tested for the controlled release of antibiotics, anti-inflammatory, and antifungal drugs in the skin for wound healing. For this purpose, the cryogels were loaded with lomefloxacin, piroxicam, and fluconazole drugs. The release of the drugs was efficiently performed in the saline buffer (pH = 7.4), and acidic solution (pH = 3), and the biocompatibility of the newly synthesized sponges was assessed over human fibroblast. The system has several advantages: it is low cost and environmentally friendly, and it has high stability and great versatility since it could be applied to several drugs.